FDA Approved: DRAXIMAGE DTPA — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)

View source ↗

Summary

The FDA approved a supplemental application for the DRAXIMAGE DTPA kit used to prepare Technetium-99m pentetate for radiopharmaceutical imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Diseases
• Renal Failure

Drugs mentioned

• DRAXIMAGE DTPA (Kit for the preparation of technetium-99m pentetate)

Snippet

SUPPL AP for DRAXIMAGE DTPA (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M PENTETATE)